Editas Medicine, Inc. (EDIT) Net income 2016–2025
Editas Medicine, Inc. (EDIT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$160.1MFY2025 · since FY2016: -$97.2M → -$160.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.1M | +32.5% |
| FY2024 | -$237.1M | -54.7% |
| FY2023 | -$153.2M | +30.5% |
| FY2022 | -$220.4M | -14.5% |
| FY2021 | -$192.5M | -66.0% |
| FY2020 | -$116.0M | +13.3% |
| FY2019 | -$133.7M | -21.6% |
| FY2018 | -$110.0M | +8.6% |
| FY2017 | -$120.3M | -23.8% |
| FY2016 | -$97.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice